Health Care Select Sector SPDR Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (59)

View All

Latest Posts

About This Stock More About This Stock
Uncertainty Grips Markets, On A Clear Day Maybe You Can See A Week Ahead
Article By: Rod Raynovich
Monday, November 28, 2022 12:59 PM EST
Healthcare stocks are now favored by many strategists because of their defensive nature and focus on US markets.
In this article: IBB, XLV Also: BMY, LLY, GILD, VRTX, XBI
Read
Sector Views: Free Cash Is King
Article By: Global X ETFs
Thursday, September 8, 2022 7:02 PM EST
Cash flow and debt sustainability are likely to become increasingly important as real economic growth slows and credit access tightens.
In this article: XLF, XLK, XLV Also: XLI, XLP, XLU, XLY, XLE, XLC
Read
Broad Market Rallies Despite Currency Headwinds
Article By: Rod Raynovich
Wednesday, July 20, 2022 4:45 AM EST
HealthCare and Biotech shares have been strong over the past 30 days as investors have sought trades away from macro and earnings concerns. In times of volatility portfolio strategists may re-balance positions toward defensive healthcare stocks.
In this article: JNJ, UNH, IHI, XBI, XLV
Read
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Article By: Rod Raynovich
Wednesday, June 22, 2022 5:36 AM EST
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
In this article: LLY, UNH, XLV, CRSP Also: CCXI, EVH, MRTX, MDGL, VCYT
Read
What’s Next For Biotech And Healthcare
Article By: Tarun Chandra, CFA
Monday, June 13, 2022 9:41 AM EST
Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform.
In this article: IBB, SPY, XLV
Read
All Posts

Latest Tweets for $XLV

No tweets yet!

PARTNER HEADLINES